An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid β Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer’s Disease-Reference-Cited by-同舟云学术

An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid β Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer’s Disease

Published:2020-10-01 Issue:20 Volume:11 Page:3346-3357
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Ju Yaojun¹,Chakravarty Harapriya¹,Tam Kin Yip¹^ORCID

Affiliation:

1. Faculty of Health Sciences, University of Macau, Avenida de Universidade, Taipa, Macau, China

Funder

Universidade de Macau

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00464

Reference56 articles.

1. Drug development in Alzheimer’s disease: the path to 2025

2. A review on Alzheimer's disease pathophysiology and its management: an update

3. Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

4. Alzheimer's disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Quinolinone Hybrids as Dual Inhibitors of Acetylcholinesterase and Aβ Aggregation for Alzheimer’s Disease Therapy;ACS Chemical Neuroscience;2023-12-27

2. Evaluations of the neuroprotective effects of a dual-target isoquinoline inhibitor in the triple transgenic mouse model of Alzheimer's disease;Neuroscience Letters;2023-04

3. Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds;Medicinal Research Reviews;2023-03-21

4. Pathological mechanisms and therapeutic strategies for Alzheimer’s disease;Neural Regeneration Research;2022

5. Unusual human serum albumin fibrillation inhibition by ketoprofen and fenoprofen: Mechanistic insights;Journal of Molecular Recognition;2021-09-09